|
|
|||||||||
CA: A Cancer Journal for Clinicians, Vol 47, Issue 4 194-197, Copyright © 1997 by American Cancer Society
K. I. Bland
The importance of considering quality-of-life issues throughout the
treatment of these cancers is evident. Although quality-of-life variables
are being delineated for cancers of various organ systems, safeguarding the
patient's sense of well being and self-esteem while preserving organ,
endocrine, exocrine, and hormonal function, fosters the best possible
quality of life for the patient in either a palliative or a curative
setting. The next millennium will usher into practice more aggressive,
targeted therapies that combine surgery, radiotherapy, and genetic and
biologic agents. The proper sequencing, administration, and toxicity of
these therapies will decrease morbidity and improve the quality of life for
patients. Above all, the healthcare provider must be aware of the patient's
personal concerns and needs for a good quality of life. The dictum espoused
by Hippocrates of "primum non nocere" ("first, do no harm") is nowhere more
appropriate than in the planning of individual therapies to achieve optimal
quality of life.
EDITORIALS
Quality-of-life management for cancer patients
This article has been cited by other articles:
![]() |
M. J. Eischens, B. A. Elliott, and T. E. Elliott Two hospice quality of life surveys: A comparison American Journal of Hospice and Palliative Medicine, May 1, 1998; 15(3): 143 - 148. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |